Pfizer abruptly settles with plaintiffs in Phila. HRT drug case that earlier ended with $72 million jury verdict

By Jon Campisi | Dec 12, 2011

Drug manufacturer Pfizer announced it has agreed to settle a consolidated civil case involving three women, two from Pennsylvania and one former Keystone State resident, who allege they developed breast cancer after taking medication designed to control menopause symptoms.

The Record Network